Literature DB >> 11162051

Understanding bacteriophage therapy as a density-dependent kinetic process.

R J Payne1, V A Jansen.   

Abstract

Studies of bacteriophage as therapeutic agents have had mixed and unpredictable outcomes. We argue that interpretation of these apparently paradoxical results requires appreciation of various density-dependent threshold effects. We use a mathematical model to delineate different categories of outcome, including therapy by simple inundation, by active biocontrol, and by delayed active biocontrol. Counter-intuitively, there are situations in which earlier inoculation can be less efficacious, and simultaneous inoculation with antibiotics can be detrimental. Predictions of therapeutic responses are made using formulae dependent on biologically meaningful parameters; experimental measurement of the parameters will be a prerequisite of application of the model to particular study systems. Such modelling can point to which aspects of phage biology might most fruitfully be engineered so as to enhance the viability of bacteriophage therapy. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11162051     DOI: 10.1006/jtbi.2000.2198

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  64 in total

1.  Overcoming the phage replication threshold: a mathematical model with implications for phage therapy.

Authors:  Laura M Kasman; Alex Kasman; Caroline Westwater; Joseph Dolan; Michael G Schmidt; James S Norris
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Evidence for a phage proliferation threshold?

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 3.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Significance of the bacteriophage treatment schedule in reducing Salmonella colonization of poultry.

Authors:  Carlota Bardina; Denis A Spricigo; Pilar Cortés; Montserrat Llagostera
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

5.  Quantifying the significance of phage attack on starter cultures: a mechanistic model for population dynamics of phage and their hosts isolated from fermenting sauerkraut.

Authors:  P Mudgal; F Breidt; S R Lubkin; K P Sandeep
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

6.  Genomic and functional analyses of Rhodococcus equi phages ReqiPepy6, ReqiPoco6, ReqiPine5, and ReqiDocB7.

Authors:  E J Summer; M Liu; J J Gill; M Grant; T N Chan-Cortes; L Ferguson; C Janes; K Lange; M Bertoli; C Moore; R C Orchard; N D Cohen; R Young
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

7.  Persistence of bacteria and phages in a chemostat.

Authors:  Hal L Smith; Horst R Thieme
Journal:  J Math Biol       Date:  2011-06-09       Impact factor: 2.259

Review 8.  Bacteriophage secondary infection.

Authors:  Stephen T Abedon
Journal:  Virol Sin       Date:  2015-01-13       Impact factor: 4.327

9.  Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.

Authors:  Marine Henry; Rob Lavigne; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

10.  A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.

Authors:  J J Bull; E R Vimr; I J Molineux
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.